Circulating biomarkers are prognostic for radium-223 benefit in mCRPC
“These results are encouraging and suggest that circulating biomarkers may be useful in guiding the use of radium-223 therapy,” says David T. Miyamoto, MD, PhD.
“These results are encouraging and suggest that circulating biomarkers may be useful in guiding the use of radium-223 therapy,” says David T. Miyamoto, MD, PhD.
“And [3 out of 5] of those patients who were initially deemed to go on to nephroureterectomy were able to be converted to endoscopic management,”…
The 2024 AUA Annual Meeting program will offer more education and innovative programming than ever before! Join us in San Antonio.
AUA2024 AQUA Forum RSVP form in San Antonio, TX.
Nogapendekin alfa inbackicept-pmin is an interleukin-15 receptor agonist.
Registration for the AUA Innovation Nexus Conference is now open. Attendees will have the opportunity to interact with program presenters, ask questions, and provide feedback…
Two of the highest profile presentations at the recent ASCO GU Meeting were the plenary presentations of the CONTACT 02 trial, and the Keynote-564 trial.…
The AUA Career Fair is a live career fair connecting urology professionals with private practices, group practices, hospitals, health systems, and other recruiters around the…
The Food and Drug Administration (FDA) has granted Fast Track designation to enibarcimab for the treatment of septic shock. Enibarcimab (formerly
“I think in terms of the 2 large tool sets we have, biomarker testing through urine or blood tests and imaging. I think both are…
The OFFICIAL site of the American Urological Association’s 2024 Annual Meeting, May 3 – May 6, 2024 in San Antonio, TX. AUA2024 explores the latest…